← Back to Search

Supplement

Phosphorus-supplemented study diet for Cardiovascular Disease

N/A

Waitlist Available

Led By Orlando Gutierrez, M.D.

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

healthy volunteers, aged 18 - 45 years with normal kidney function (estimated glomerular filtration rate > 60 ml/min/1.73m2).

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 7 days

Awards & highlights

Study Summary

This trial will study the effects of phosphorus supplementation on the human metabolome by conducting a cross-over study with two different diets.

Eligible Conditions

Cardiovascular Disease
Insulin Sensitivity
Metabolic Syndrome

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 7 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~7 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Untargeted Metabolomics

Secondary outcome measures

Fibroblast growth factor 23 (FGF23)

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Phosphorus-supplemented study dietExperimental Treatment1 Intervention

Participants will be instructed to consume a normal diet with supplemental phosphorus (K-Phos Neutral tablets, 250 mg; 4 tablets a day) for 1 week.

Group II: Control dietPlacebo Group1 Intervention

Participants will be asked to consume a normal diet supplemented with sodium chloride (sodium chloride tablets, USP, 1 gram; 3 tablets per day) and potassium chloride (Klor-Con, 8 mEq; 0.5 tablets per day) for 1 week.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor

1,590 Previous Clinical Trials

2,281,432 Total Patients Enrolled

Orlando Gutierrez, M.D.Principal InvestigatorUniversity of Alabama at Birmingham

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still available slots for individuals to enroll in this clinical experiment?

"According to clinicaltrials.gov, this medical investigation is not presently soliciting participants. The study was initially posted on June 28th 2019 and the last edit was made on April 8th 2022. While no longer accepting patients, there are 693 other trials actively seeking volunteers at this moment in time."

Answered by AI